Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

Eitemau Tebyg

• Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
  gan: Hox, Valerie, et al.
  Cyhoeddwyd: (2020)
• Diagnostic tools in Rhinology EAACI position paper
  gan: Scadding, Glenis, et al.
  Cyhoeddwyd: (2011)
• A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
  gan: Hellings, Peter, et al.
  Cyhoeddwyd: (2015)
• MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
  gan: Scadding, Glenis, et al.
  Cyhoeddwyd: (2015)
• A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity.
  gan: Bachert, Claus, et al.
  Cyhoeddwyd: (2015)